These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

982 related items for PubMed ID: 6500548

  • 1. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma.
    Clark WH, Elder DE, Guerry D, Epstein MN, Greene MH, Van Horn M.
    Hum Pathol; 1984 Dec; 15(12):1147-65. PubMed ID: 6500548
    [Abstract] [Full Text] [Related]

  • 2. Atypical melanocytic nevi of the genital type with a discussion of reciprocal parenchymal-stromal interactions in the biology of neoplasia.
    Clark WH, Hood AF, Tucker MA, Jampel RM.
    Hum Pathol; 1998 Jan; 29(1 Suppl 1):S1-24. PubMed ID: 9445124
    [Abstract] [Full Text] [Related]

  • 3. Deep penetrating nevus-like borderline tumors: A unique subset of ambiguous melanocytic tumors with malignant potential and normal cytogenetics.
    Magro CM, Abraham RM, Guo R, Li S, Wang X, Proper S, Crowson AN, Mihm M.
    Eur J Dermatol; 2014 Jan; 24(5):594-602. PubMed ID: 25118781
    [Abstract] [Full Text] [Related]

  • 4. The developmental biology of primary human malignant melanomas.
    Clark WH, Ainsworth AM, Bernardino EA, Yang CH, Mihm CM, Reed RJ.
    Semin Oncol; 1975 Jun; 2(2):83-103. PubMed ID: 790575
    [Abstract] [Full Text] [Related]

  • 5. [Unusual and unknown aspect of cutaneous malignant melanoma: minimal deviation malignant melanoma. Retrospective study of 45 cases].
    Mérot Y, Mihm MC.
    Ann Dermatol Venereol; 1985 Jun; 112(4):325-36. PubMed ID: 4026131
    [Abstract] [Full Text] [Related]

  • 6. A hypothesis incorporating the histologic characteristics of dysplastic nevi into the normal biological development of melanocytic nevi.
    Piepkorn M.
    Arch Dermatol; 1990 Apr; 126(4):514-8. PubMed ID: 2321996
    [Abstract] [Full Text] [Related]

  • 7. Tumor progression in the human melanocytic system.
    Kath R, Rodeck U, Menssen HD, Mancianti ML, Linnenbach AJ, Elder DE, Herlyn M.
    Anticancer Res; 1989 Apr; 9(4):865-72. PubMed ID: 2554787
    [Abstract] [Full Text] [Related]

  • 8. Parenchymal-stromal interactions in neoplasia. Theoretical considerations and observations in melanocytic neoplasia.
    Clark WH, Tucker MA, Goldstein AM.
    Acta Oncol; 1995 Apr; 34(6):749-57. PubMed ID: 7576741
    [Abstract] [Full Text] [Related]

  • 9. Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions.
    Miracco C, Cevenini G, Franchi A, Luzi P, Cosci E, Mourmouras V, Monciatti I, Mannucci S, Biagioli M, Toscano M, Moretti D, Lio R, Massi D.
    Hum Pathol; 2010 Apr; 41(4):503-12. PubMed ID: 20004946
    [Abstract] [Full Text] [Related]

  • 10. Melanocytic nevi and melanoma: unraveling a complex relationship.
    Damsky WE, Bosenberg M.
    Oncogene; 2017 Oct 19; 36(42):5771-5792. PubMed ID: 28604751
    [Abstract] [Full Text] [Related]

  • 11. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma?
    Skender-Kalnenas TM, English DR, Heenan PJ.
    J Am Acad Dermatol; 1995 Dec 19; 33(6):1000-7. PubMed ID: 7490345
    [Abstract] [Full Text] [Related]

  • 12. Proliferative activity of primary cutaneous melanocytic tumours.
    Kuwata T, Kitagawa M, Kasuga T.
    Virchows Arch A Pathol Anat Histopathol; 1993 Dec 19; 423(5):359-64. PubMed ID: 7906909
    [Abstract] [Full Text] [Related]

  • 13. The usefulness of c-Kit in the immunohistochemical assessment of melanocytic lesions.
    Pilloni L, Bianco P, Difelice E, Cabras S, Castellanos ME, Atzori L, Ferreli C, Mulas P, Nemolato S, Faa G.
    Eur J Histochem; 2011 Jun 07; 55(2):e20. PubMed ID: 22193299
    [Abstract] [Full Text] [Related]

  • 14. Common acquired melanocytic nevi, melanocytic dysplasia and malignant melanoma. A morphometric study.
    Santucci M, Urso C, Giannini A, Bondi R.
    Appl Pathol; 1989 Jun 07; 7(2):111-5. PubMed ID: 2730799
    [Abstract] [Full Text] [Related]

  • 15. The initial steps of tumor progression in melanocytic lineage: a histochemical approach.
    Wollina U, Kilian U, Henkel U, Schaarschmidt H, Knopf B.
    Anticancer Res; 1991 Jun 07; 11(4):1405-14. PubMed ID: 1746897
    [Abstract] [Full Text] [Related]

  • 16. The relationship between melanocytes and peripheral nerve sheath cells (Part I): melanocytic nevus (excluding so-called "blue nevus") with peripheral nerve sheath differentiation.
    Misago N.
    Am J Dermatopathol; 2000 Jun 07; 22(3):217-29. PubMed ID: 10871064
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Role of In Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions.
    Serban ED, Farnetani F, Pellacani G, Constantin MM.
    Acta Dermatovenerol Croat; 2018 Apr 07; 26(1):64-67. PubMed ID: 29782304
    [Abstract] [Full Text] [Related]

  • 19. Increased epidermal growth factor receptors in melanocytic lesions.
    Ellis DL, King LE, Nanney LB.
    J Am Acad Dermatol; 1992 Oct 07; 27(4):539-46. PubMed ID: 1383295
    [Abstract] [Full Text] [Related]

  • 20. Melanoma precursor lesions and borderline melanomas.
    Briggs JC.
    Histopathology; 1985 Dec 07; 9(12):1251-62. PubMed ID: 3913633
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.